Entelai
Buenos Aires, AR · Founded 2018 · 1 known investors
Entelai develops clinically validated artificial intelligence tools for medicine, including diagnostic support for neurological conditions such as multiple sclerosis and headache assessment via brain MRI analysis. It serves healthcare professionals, medical institutions and patients across Latin America, and also offers an online service for medical prescriptions and studies.
Founders & leadership
Entelai was founded in 2018 by Mauricio Franco Farez.
MF
Mauricio Franco FarezFounder
Investors · 1
Reported raises · per SEC filings
Form D private placements$200K disclosed across 1 round · 2019
▶$200KraisedNov 2019 · 1 investors · OtherRule 506(b)
▶$200KraisedNov 2019 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Mauricio Franco FarezExecutive Officer
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Oct 2019
- Incorporated
- Limited Liability Company, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Entelai do?
- Entelai develops clinically validated artificial intelligence tools for medicine, including diagnostic support for neurological conditions such as multiple sclerosis and headache assessment via brain MRI analysis. It serves healthcare professionals, medical institutions and patients across Latin America, and also offers an online service for medical prescriptions and studies.
- Who founded Entelai?
- Entelai was founded by Mauricio Franco Farez in 2018.
- Who are Entelai's investors?
- Entelai's investors include Alaya Capital.
- How much funding has Entelai raised?
- Entelai has disclosed $200K raised across 1 round.
- Where is Entelai headquartered?
- Entelai is headquartered in Buenos Aires, AR.